Totient

Developer of a drug discovery platform for cancer and autoimmune disease by using artificial intelligence

placeCambridge, Massachusetts, United States calendar_todayFounded 2017 groups26 employees language totient.bio

Registered entities

Investor mix

15 investors on record; lead investors include Tau Ventures, Kaitai Capital Management, Viva Biotech, Sands Capital.

Investor typeCountShare
Venture capital1173%
Private equity17%
Accelerator & incubator17%
Other / undisclosed213%
Coming soon